No conviction changes recorded
Upgrade to premium to see the full reasoning behind each conviction change.
Sign in to unlockFair Value Distribution — percentile bands
45.6% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
4.7%/yr
±12.1% · revenue growth to justify current price
FCF-Based Reverse DCF
71.7%/yr
±4.8% · FCF growth to justify current price
THE GAP
Market pricing margin compression or rising capex
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockCrop nutrient demand is inelastic — global food security imperative underpins long-term prices. If potash/phosphate recover to mid-cycle, MOS trades at 6-7x EBITDA vs current ~9x on trough earnings. Cheap on a recovery basis.
FY2025 revealed structural margin compression. Commodity deflation may persist with Brazilian potash production expanding. Asset write-offs signal impairment culture. Debt refinanced at worse rates. No near-term catalyst.
Potash price falls below /t; second consecutive year of EBITDA margin below 15%; further impairment charges on major assets
Updated Mar 16
FY2025 marked a strategic inflection: Mosaic aggressively divested underperforming assets (Patos de Minas, Taquari, Carlsbad) while refinancing debt at higher rates (4.35-4.60%). Revenue headwinds fro...